566 related articles for article (PubMed ID: 29572094)
1. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
[TBL] [Abstract][Full Text] [Related]
2. Fazirsiran for Liver Disease Associated with Alpha
Strnad P; Mandorfer M; Choudhury G; Griffiths W; Trautwein C; Loomba R; Schluep T; Chang T; Yi M; Given BD; Hamilton JC; San Martin J; Teckman JH
N Engl J Med; 2022 Aug; 387(6):514-524. PubMed ID: 35748699
[TBL] [Abstract][Full Text] [Related]
3. Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
Wooddell CI; Blomenkamp K; Peterson RM; Subbotin VM; Schwabe C; Hamilton J; Chu Q; Christianson DR; Hegge JO; Kolbe J; Hamilton HL; Branca-Afrazi MF; Given BD; Lewis DL; Gane E; Kanner SB; Teckman JH
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32379724
[TBL] [Abstract][Full Text] [Related]
4. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P;
Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
Fromme M; Hamesch K; Schneider CV; Mandorfer M; Pons M; Thorhauge KH; Pereira V; Sperl J; Frankova S; Reichert MC; Benini F; Burbaum B; Kleinjans M; Amzou S; Rademacher L; Bewersdorf L; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Waern J; Oliveira A; Maia L; Simões C; Mahadeva R; Fraughen DD; Trauner M; Krag A; Lammert F; Bals R; Gaisa NT; Aigner E; Griffiths WJ; Denk H; Teumer A; McElvaney NG; Turner AM; Trautwein C; Strnad P
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):283-294.e5. PubMed ID: 37716616
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
10. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of children with α-1 antitrypsin deficiency.
Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
[TBL] [Abstract][Full Text] [Related]
12. RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease.
Strnad P; San Martin J
Expert Opin Investig Drugs; 2023; 32(7):571-581. PubMed ID: 37470509
[TBL] [Abstract][Full Text] [Related]
13. An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.
Lechowicz U; Martinez-Delgado B; Liu B; Wrenger S; Rozy A; Zdral A; DeLuca DS; Welte T; Janciauskiene S; Chorostowska-Wynimko J
Clin Biochem; 2024 Apr; 126():110736. PubMed ID: 38428450
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
[TBL] [Abstract][Full Text] [Related]
15. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
[TBL] [Abstract][Full Text] [Related]
17. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
18. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
Carey EJ; Iyer VN; Nelson DR; Nguyen JH; Krowka MJ
Liver Transpl; 2013 Dec; 19(12):1370-6. PubMed ID: 24019185
[TBL] [Abstract][Full Text] [Related]
19. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
